
For many people, the superbug MRSA, also called methicillin-resistant staphylococcus aureus, is a dreadful bacterium and that’s because it is not responsive to any treatment. This bacterium is known to have killed almost 3,000 Americans in 2013.
Superbug MRSA can now become history, study reveals. The study was published in Nature Communications journal.
For many people, the superbug MRSA, also called methicillin-resistant staphylococcus aureus, is a dreadful bacterium and that’s because it is not responsive to any treatment. This bacterium is known to have killed almost 3,000 Americans in 2013. Other people face infections which lead to dangerous complications which can end with losing a limb, for example.
For many years, public officials struggled to discover an efficient treatment, but they just couldn’t. Now the new study promises a solution against MRSA: tamoxifen.
Tamoxifen is a widely-known breast cancer pill used not only for treatment, but also for prevention. Apart from its role of fighting against tumors, this drug also creates extracellular traps which help the body fight against infections.
Researchers from the University of California made the test on mice. They injected the animals not only with tamoxifen, but also with a big quantity of MRSA. They observed that the chances of surviving increased by a third. Researcher Victor Nizet declared that this is a preliminary research and more research is needed before the testing could be applied on humans.
“We believe this is part of the larger need that we have in medicine to move to a more holistic approach to treating infections,” he declared.
Scientists also tested other methods in order to fight MRSA. At the beginning of this year, they said that a remedy made up of garlic, onion, copper, wine and ox gall could show some benefits as well.
Doctors hope that in the future these treatments will help people such as Daniel Fells, a player from Giants, to fight against this infection. On Sunday, New York Giants dedicated their game to Fells.
Image Source: Pixabay